Acute myeloid leukaemia: optimal management and recent developments.

Item

http://www.wikidata.org/entity/Q36914091

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Acute myeloid leukaemia: optimal management and recent developments.

@en

type

Item

label

Acute myeloid leukaemia: optimal management and recent developments.

@en

prefLabel

Acute myeloid leukaemia: optimal management and recent developments.

@en

P1476

Acute myeloid leukaemia: optimal management and recent developments.

@en

P2093

Javier Bolaños-Meade

http://www.w3.org/2001/XMLSchema#string

Luis Villela

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

The role of FLT3 in haematopoietic malignancies

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations.

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype.

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype.

Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia.

Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.

P2888

11593060-000000000-00000

P304

1537-1550

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11593060-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1006244455

http://www.w3.org/2001/XMLSchema#string

P698

21861539

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

3676948

http://www.w3.org/2001/XMLSchema#string